CIB0.DE vs. 2B78.DE
CIB0.DE (VanEck Bionic Engineering UCITS ETF A) and 2B78.DE (iShares Healthcare Innovation UCITS ETF) are both Health & Biotech Equities funds - CIB0.DE tracks the MVIS Global Bionic Healthcare ESG while 2B78.DE tracks the iSTOXX® FactSet Breakthrough Healthcare. Both are passively managed. Over the past 3 years, CIB0.DE returned -8.20%/yr vs 2.27%/yr for 2B78.DE. A 0.70 correlation means they provide meaningful diversification when combined. CIB0.DE charges 0.55%/yr vs 0.40%/yr for 2B78.DE.
Performance
CIB0.DE vs. 2B78.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CIB0.DE achieves a -14.18% return, which is significantly lower than 2B78.DE's -2.07% return.
CIB0.DE
- 1D
- 3.05%
- 1M
- 1.36%
- YTD
- -14.18%
- 6M
- -17.46%
- 1Y
- -15.36%
- 3Y*
- -8.20%
- 5Y*
- —
- 10Y*
- —
2B78.DE
- 1D
- 0.41%
- 1M
- 1.41%
- YTD
- -2.07%
- 6M
- -3.15%
- 1Y
- 14.42%
- 3Y*
- 2.27%
- 5Y*
- -1.74%
- 10Y*
- —
CIB0.DE vs. 2B78.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CIB0.DE VanEck Bionic Engineering UCITS ETF A | -14.18% | -10.00% | 5.16% | 2.09% | -1.65% |
2B78.DE iShares Healthcare Innovation UCITS ETF | -2.07% | 5.50% | 7.24% | -0.29% | -3.36% |
Correlation
The correlation between CIB0.DE and 2B78.DE is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Dec 8, 2022 | 0.70 |
The correlation between CIB0.DE and 2B78.DE has been stable across timeframes, ranging from 0.63 to 0.70 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CIB0.DE vs. 2B78.DE — Risk / Return Rank
CIB0.DE
2B78.DE
CIB0.DE vs. 2B78.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and iShares Healthcare Innovation UCITS ETF (2B78.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CIB0.DE | 2B78.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.84 | ||
| Sortino ratioReturn per unit of downside risk | -2.65 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.17 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.65 | 1.24 | -1.88 |
| Martin ratioReturn relative to average drawdown | -1.67 | 3.07 | -4.75 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CIB0.DE | 2B78.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.89 | 0.95 | -1.84 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.10 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | 0.31 | -0.62 |
Drawdowns
CIB0.DE vs. 2B78.DE - Drawdown Comparison
The maximum CIB0.DE drawdown since its inception was -32.60%, smaller than the maximum 2B78.DE drawdown of -38.58%. Use the drawdown chart below to compare losses from any high point for CIB0.DE and 2B78.DE.
Loading charts...
Drawdown Indicators
| CIB0.DE | 2B78.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.60% | -38.58% | +5.98% |
Max Drawdown (1Y)Largest decline over 1 year | -23.47% | -12.05% | -11.42% |
Max Drawdown (3Y)Largest decline over 3 years | -32.60% | -25.32% | -7.28% |
Max Drawdown (5Y)Largest decline over 5 years | — | -36.99% | — |
Current DrawdownCurrent decline from peak | -28.26% | -19.03% | -9.23% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -14.36% | +3.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.08% | 4.86% | +4.22% |
Volatility
CIB0.DE vs. 2B78.DE - Volatility Comparison
VanEck Bionic Engineering UCITS ETF A (CIB0.DE) has a higher volatility of 6.42% compared to iShares Healthcare Innovation UCITS ETF (2B78.DE) at 3.74%. This indicates that CIB0.DE's price experiences larger fluctuations and is considered to be riskier than 2B78.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CIB0.DE | 2B78.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 3.74% | +2.68% |
Volatility (6M)Calculated over the trailing 6-month period | 12.62% | 10.97% | +1.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.03% | 15.67% | +1.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.95% | 17.91% | +0.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.95% | 18.79% | -0.84% |
CIB0.DE vs. 2B78.DE - Expense Ratio Comparison
CIB0.DE has a 0.55% expense ratio, which is higher than 2B78.DE's 0.40% expense ratio.
Dividends
CIB0.DE vs. 2B78.DE - Dividend Comparison
Neither CIB0.DE nor 2B78.DE has paid dividends to shareholders.
Frequently Asked Questions
CIB0.DE and 2B78.DE have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B78.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B78.DE is cheaper with a 0.40% expense ratio, compared with 0.55% for CIB0.DE.
CIB0.DE tracks MVIS Global Bionic Healthcare ESG, while 2B78.DE tracks iSTOXX® FactSet Breakthrough Healthcare. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.55% for CIB0.DE and 0.40% for 2B78.DE.
Find the right allocation for CIB0.DE and 2B78.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer